Myanmar Business Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Myanmar Business Daily.

Press releases published on July 2, 2026

Jul. 2, 2026

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.0833 per Share

Indeterminate GlobeNewswire

Jul. 2, 2026

Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Robinhood Markets, Inc. to Announce Second Quarter 2026 Results on July 29, 2026

Indeterminate GlobeNewswire

Jul. 2, 2026

Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026

Indeterminate GlobeNewswire

Jul. 2, 2026

CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors

Indeterminate GlobeNewswire

Jul. 2, 2026

Rush Enterprises, Inc. Conference Call Advisory for Second Quarter 2026 Earnings Call

Indeterminate GlobeNewswire

Jul. 2, 2026

vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Spyre Therapeutics Announces Grants of Inducement Awards

Indeterminate GlobeNewswire

Jul. 2, 2026

Covenant Logistics Group, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call

Indeterminate GlobeNewswire

Jul. 2, 2026

Patria Investments successfully raises over USD 670m for its Secondary Opportunities Fund V

Indeterminate GlobeNewswire

Jul. 2, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

MANH Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Manhattan Associates, Inc. – MANH

Indeterminate GlobeNewswire

Jul. 2, 2026

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)

Indeterminate GlobeNewswire

Jul. 2, 2026

Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026

Indeterminate GlobeNewswire

Jul. 2, 2026

Résultats des Votes de l’Assemblée Générale Mixte des Actionnaires Réunie le 30 juin 2026

Indeterminate GlobeNewswire

Jul. 2, 2026

Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

Indeterminate GlobeNewswire